Prequalification workshop for manufacturers of IVDs
IVD
EUL for IVDs – Bundibugyo virus (BDBV) nucleic acid detection
IVD
WHO has published detailed submission instructions for the Emergency Use Listing (EUL) of in vitro diagnostics for Bundibugyo virus disease (BDBV)
WHO's Public Assessment Reports (WHOPAR) Update 17 April to 27 May 2026
IVD
Between 17 April and 27 May 2026, several WHO Public Assessment Reports (WHOPARs) were updated to reflect changes in product labelling, documentation, and other relevant post-prequ
41st Invitation of Active Pharmaceutical Ingredients (APIs)
M
The following APIs were added:
1st Invitation to manufacturers of medicinal products for treatment of substance use disorders, to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit
M
The 1st Invitation to manufacturers of medicinal products for treatment of substance use disorders to submit an application for product evaluation by prequalification has been issued based on a req
3rd Invitation to Manufacturers of medicinal products for management of diabetes to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit
M
The Invitation to Manufacturers of human insulin and insulin analogues was recently updated and renamed as Invitation to Manufacturers of medicinal products for management of diabetes to Submit an